211.75
-8.23
(-3.74%)
At close: April 9 at 6:43:25 PM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 3 | 10 | 8 |
| Avg. Estimate | 328.79M | 337M | 1.41B | 1.62B |
| Low Estimate | 304M | 321M | 1.16B | 1.42B |
| High Estimate | 348M | 353.52M | 1.53B | 1.75B |
| Year Ago Sales | 256.8M | 260.1M | 1.11B | 1.41B |
| Sales Growth (year/est) | 28.03% | 29.56% | 26.32% | 15.39% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 0QYZ.L | -- | -- | -- | -- |
| S&P 500 | 6.52% | 6.29% | 9.55% | 14.25% |
Upgrades & Downgrades
| Maintains | Raymond James: Outperform to Outperform | 4/4/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/26/2025 |
| Downgrade | TD Securities: Buy to Hold | 3/11/2025 |
| Maintains | UBS: Buy to Buy | 3/11/2025 |
| Maintains | Scotiabank: Sector Perform to Sector Perform | 3/11/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 3/11/2025 |